Share

    


Home / Search Results

Search Results

You searched for:

October 21, 2020
COVID-19 has impacted how providers are dispensing multiple myeloma medications and providing care to patients during the pandemic. Learn how to identify those effects to help mitigate them and implement strategies to improve telehealth medicine during the pandemic.
April 27, 2021
Panelists discussed considerations for resuming pre-pandemic level visits and procedures for patients with CLL, AML, and Multiple Myeloma. Hear wins and challenges in providing care in a pandemic.
February 10, 2021
An expert panel of past ACCC Presidents will share their perspectives on changes to clinical research during the pandemic.
May 25, 2021
Hear considerations for treating patients with CLL during the pandemic, including best options, treatment timing, changes to the usual regimen, and how to prepare for the future.
Dr. Barbara Schmidtman highlights key findings from the 2022 ACCC Mini Z burnout survey, comparing results from the pre-pandemic 2019 to now.
This study examined the coping strategies and psychosocial well-being of patients with lung cancer facing multiple stressors, primarily due to the COVID-19 pandemic.
In addition to the global pandemic, ongoing lawsuits from referenced biologics' manufacturers suing biosimilar manufacturers are having a negative impact on the development and approval of new biosimilars.
Because of the COVID-19 pandemic, Wilmot Cancer Institute's integrative oncology team shares how integrative oncology-based services can be delivered via telehealth.
Put yourself first: this mantra is especially important today as we continue to grapple with the implications and fallout from the COVID-19 global pandemic.
Before the COVID-19 pandemic, patients with cancer received care in three settings: hospital inpatient, hospital emergency room, and the outpatient clinic. But just as the pandemic overturned deep-rooted barriers to telehealth uptake, it also brought renewed attention to the hospital-at-home model.
On Tuesday, March 2, AMCCBS Virtual will focus on timely, real-world case studies from organizations that used the opportunities created by the pandemic to forge new paths forward. On March 2, sessions will focus on telehealth, virtual care, and remote monitoring. Speakers will address and lead conversations about the multiple and changing roles of telehealth during the COVID-19 pandemic.
With the COVID-19 pandemic resulting in unprecedented unemployment and an economic recession, financial advocacy services for cancer patients are more important than ever. At any given time, the job of financial advocates and navigators requires them to stay on top of rapidly changing assistance programs, insurance coverage changes, new state healthcare laws, and evolving community resources. The pandemic …
The COVID-19 pandemic has had a negative impact in the rate of cancer screening across various states in the United States. Louisiana, Delaware, Kentucky and Northern Michigan serve as vehicles for an analysis of the disparity in cancer screening rates, before and after the pandemic.
June 19, 2020
Join a panel of Montefiore Health System providers for an in-depth look at their pandemic preparations and response and how they’re collecting data for care coordination and research. (June 19, 2020)
July 29, 2020
Financial advocacy experts will come together to discuss critical financial advocacy tips that can benefit your patients and your cancer program during the economic crisis resulting from the pandemic. (July 29, 2020)
May 20, 2021
The pandemic has heightened the distress patients with CLL face and taken its toll on providers. Learn strategies and solutions to these challenges and the path forward for providing patient care.
May 8, 2020
Shelli Laux, MBA, RHIA, CTR, CCRP, WellSpan Health, shares an overview of effective practices for virtual tumor boards, methods for ensuring attendance and participation, and insights into post-pandemic sustainability. (May 8, 2020)
To meet patients’ needs during the height of the pandemic, this cancer program created a collaborative and more efficient hybrid-style Integrative Therapy Program for all of its oncology sites.
COVID-19 has brought an unexpected, unwelcome, and unwanted disruption to oncology care, as it has to every other facet of life. ACCC has met this unprecedented pandemic, however, with its characteristic “how to” approach.
As the public health emergency comes to an end, cancer programs and practices, as well as their providers, must prepare to return to pre-pandemic billing practice standards.